Latest Regulatory Compliance News

Page 4 of 90
The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Biotron Limited’s BITO securities have been suspended from ASX trading due to non-compliance with key listing rules, raising questions about the company’s next steps.
Ada Torres
Ada Torres
15 Dec 2025
Nova Minerals Limited has voluntarily suspended trading of its shares on the ASX pending a capital raising announcement expected on 17 December 2025.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.
Maxwell Dee
Maxwell Dee
12 Dec 2025
Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.
Maxwell Dee
Maxwell Dee
12 Dec 2025
Assetora Limited has updated its previous placement announcements, confirming that the issuance of shares to Cardio Link and Creative Capital Management will now require shareholder approval at an upcoming EGM likely scheduled for late January 2026.
Claire Turing
Claire Turing
12 Dec 2025
Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.
Maxwell Dee
Maxwell Dee
12 Dec 2025
NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.
Sophie Babbage
Sophie Babbage
12 Dec 2025
Miramar Resources has completed its Tranche 1 share placement and secured a further $205,000 commitment from a director for Tranche 2, pending shareholder approval in early 2026.
Maxwell Dee
Maxwell Dee
12 Dec 2025
Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.
Ada Torres
Ada Torres
12 Dec 2025
Minbos Resources has updated the schedule for its Placement and Share Purchase Plan, delaying the SPP opening to mid-December with completion expected by early February 2026.
Maxwell Dee
Maxwell Dee
11 Dec 2025
Locate Technologies Limited will be suspended from ASX trading following court approval of a scheme making Locate NZ the new parent company.
Sophie Babbage
Sophie Babbage
11 Dec 2025